The Relationship Between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 May 11

PMID 38731112

Authors

Zdenko Bilic

Mario Zovak

Goran Glavcic

Dubravka Muzina

Amir Ibukic

Andro Kosec

Davor Tomas

Alma Demirovic

Affiliations

Soon will be listed here.

Abstract

Recently, some new morphological features of colorectal cancer have been discovered as important prognostic factors; in this paper, we study the relationship between tumor budding (TB) and tumor deposits (TDs). The retrospective cohort study included 90 patients with pathohistologically confirmed stage III CRC who were treated with radical surgical resection. All hematoxylin and eosin (H and E)-stained slides from each patient were reviewed, and histological parameters were recorded. The samples were divided into two groups with similar sizes: a group without TDs (N = 51) and a control group with TDs (N = 39). The presence and TB grade were further analyzed in these groups and compared with other clinical and histological features. The prevalence of TB in the investigated cohort was unexpectedly high (94.4%). Overall, there were 23 (25.6%) Bd1, 20 (22.2%) Bd2, and 47 (52.2%) Bd3 cases. The presence of TDs was significantly associated with a higher number of TB ( < 0.001, OR 16.3) and, consequently, with a higher TB grade ( = 0.004, OR 11.04). A higher TB grade ( = 0.001, HR 2.28; 95% CI 1.93-4.76) and a growing number of TDs ( = 0.014, HR 1.52; 95% CI 1.09-2.1) were statistically significantly associated with shorter survival. TDs appear more often in patients with higher TB grades in stage III CRC. A higher TB grade and a growing number of TDs were statistically significantly associated with shorter overall survival. These results could give additional emphasis to the importance of TB as an adverse prognostic factor since a strong relationship with TDs has been demonstrated.

References

Shinto E, Mochizuki H, Ueno H, Matsubara O, Jass J . A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology. 2005; 47(1):25-31. DOI: 10.1111/j.1365-2559.2005.02162.x. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Nagtegaal I, Quirke P . Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007; 51(2):141-9. DOI: 10.1111/j.1365-2559.2007.02720.x. View

Prabhudesai A, Arif S, Finlayson C, Kumar D . Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum. 2003; 46(11):1531-7. DOI: 10.1007/s10350-004-6809-5. View

Ueno H, Murphy J, Jass J, Mochizuki H, Talbot I . Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002; 40(2):127-32. DOI: 10.1046/j.1365-2559.2002.01324.x. View

Koelzer V, Canonica K, Dawson H, Sokol L, Karamitopoulou-Diamantis E, Lugli A . Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome. Oncoimmunology. 2016; 5(4):e1106677. PMC: 4839334. DOI: 10.1080/2162402X.2015.1106677. View

Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Matsuda C . Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial. J Clin Oncol. 2019; 37(22):1886-1894. PMC: 6675595. DOI: 10.1200/JCO.18.02059. View

Lugli A, Karamitopoulou E, Zlobec I . Tumour budding: a promising parameter in colorectal cancer. Br J Cancer. 2012; 106(11):1713-7. PMC: 3364122. DOI: 10.1038/bjc.2012.127. View

Zlobec I, Berger M, Lugli A . Tumour budding and its clinical implications in gastrointestinal cancers. Br J Cancer. 2020; 123(5):700-708. PMC: 7462864. DOI: 10.1038/s41416-020-0954-z. View

10.

Dawson H, Blank A, Zlobec I, Lugli A . Potential clinical scenarios of tumour budding in colorectal cancer. Acta Gastroenterol Belg. 2020; 82(4):515-518. View

11.

van Wyk H, Park J, Edwards J, Horgan P, McMillan D, Going J . The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Br J Cancer. 2016; 115(2):156-63. PMC: 4947698. DOI: 10.1038/bjc.2016.173. View

12.

Kim H, Choi G . Clinical Implications of Lymph Node Metastasis in Colorectal Cancer: Current Status and Future Perspectives. Ann Coloproctol. 2019; 35(3):109-117. PMC: 6625771. DOI: 10.3393/ac.2019.06.12. View

13.

Ueno H, Mochizuki H, Hashiguchi Y, Hatsuse K, Fujimoto H, Hase K . Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg. 2004; 91(3):327-33. DOI: 10.1002/bjs.4429. View

14.

Puppa G, Sonzogni A, Colombari R, Pelosi G . TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med. 2010; 134(6):837-52. DOI: 10.5858/134.6.837. View

15.

Ueno H, Mochizuki H, TAMAKUMA S . Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum. 1998; 41(1):55-61. DOI: 10.1007/BF02236896. View

16.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

17.

Zlobec I, Lugli A . Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2011; 1(7):651-61. PMC: 3248128. DOI: 10.18632/oncotarget.199. View

18.

Belt E, van Stijn M, Bril H, de Lange-de Klerk E, Meijer G, Meijer S . Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol. 2010; 17(12):3203-11. PMC: 2995864. DOI: 10.1245/s10434-010-1152-7. View

19.

Jurescu A, Dema A, Vaduva A, Gheju A, Vita O, Barna R . Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas. Bosn J Basic Med Sci. 2021; 22(2):164-177. PMC: 8977077. DOI: 10.17305/bjbms.2021.6110. View

20.

Luo Y, Yan Z, Liu J, Li X, Yang M, Fan J . Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer. World J Gastroenterol. 2024; 30(2):158-169. PMC: 10835523. DOI: 10.3748/wjg.v30.i2.158. View